Skip to content

Toxicity of ayahuasca after 28 days daily exposure and effects on monoamines and brain-derived neurotrophic factor (BDNF) in brain of Wistar rats

Camila Schoueri Colaço, Stefany Sousa Alves, Luciana Marangni Nolli, Willie Oliveira Pinheiro, Danilo Gustavo Rodrigues de Oliveira, Beatriz Werneck Lopes Santos, Aline Pic‐taylor, Márcia Renata Mortari, Eloísa Dutra Caldas

Metabolic Brain Disease February 27, 2020 DOI: 10.1007/s11011-020-00547-w (opens in new tab)

The journal has published a correction to this paper. Read the correction (opens in new tab)

Relevant Not relevant

Study at a glance

AI-extracted from the abstract
Characteristics Animal study Peer reviewed
Population Female and male rats
Interventions Ayahuasca Fluoxetine
Dose 0.5X, 1X and 2X the ritualistic dose
Duration 28 days
Topics Ayahuasca Serotonin
Keywords Monoamine neurotransmitter Dopamine Brain-derived neurotrophic factor Antidepressant Pharmacology Neurotrophic factors Serotonin reuptake inhibitor Endocrinology Hallucinogen
Citations 56
Key points Ayahuasca was safe in rats after chronic exposure and increased serotonin, dopamine turnover, and hippocampal BDNF levels in a dose- and sex-dependent manner.

Abstract

Ayahuasca is a hallucinogenic beverage that affects the serotonergic system and have therapeutic potential for many diseases and disorders, including depression and drug addiction. The objectives of this study were to evaluate the potential toxic effects of ayahuasca on rats after chronic exposure, and the levels of monoamines, their metabolites and the brain-derived neurotrophic factor (BDNF) in the brain. Female and male rats were treated orally for 28 days with H2O (control), fluoxetine (FLX), a selective serotonin reuptake inhibitor antidepressant, or ayahuasca (Aya) at doses of 0.5X, 1X and 2X the ritualistic dose (7 to 10 animals/group). Clinical, hematological and macroscopic results showed that ayahuasca was safe to the rats. Behavior tests conducted one hour after the last treatment showed that male rats from the Aya1 group explored the open field central area less than the control group, and the number of entries in the central area compared to total locomotion was also significantly lower in this group and in the FLX group. The hippocampus was removed for BDNF analysis and the remaining brain was used for monoamine analysis by HPLC-FL. Serotonin levels were significantly higher than control only in the Aya2 female group, while a significant reduction of its metabolite 5-HIAA was observed in the FLX group. Dopamine levels were similar among the experimental groups, but the levels of its metabolite DOPAC increased significantly in the Aya1 and Aya2 groups compared to controls, especially in females, and the DOPAC/dopamine turnover was significantly higher in Aya2 group. The levels of HVA, another dopamine metabolite, did not change with the treatments compared to controls, but HVA/DOPAC ratio was significantly lower in all ayahuasca male groups. Norepinephrine was not detected in any brain sample, and the levels of its metabolite MHPG did not change significantly among the groups. BDNF levels in the hippocampus were significantly higher in the FLX and Aya2 female groups compared to controls when expressed in relation to the total brain weight. The mechanisms involved in the increase in serotonin, dopamine turnover and BDNF levels observed in ayahuasca treated animals should be further investigated in specific brain areas.

Comparable studies

Other preclinical and animal studies on ayahuasca, most cited first.

Study Year Design Participants
Monoamine oxidase inhibitors in South American hallucinogenic plants: Tryptamine and β-carboline constituents of Ayahuasca Eight ayahuasca samples from Peru and several Banisteriopsis caapi cultivars 1984 Qualitative and quantitative chemical analysis with in vitro assay
The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro Progenitor cells from subventricular and subgranular zones of adult mice brains 2017 In vitro experimental study
N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo Mice 2020 In vitro and in vivo experimental study
Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat Female Wistar rats 2015 Observational cohort
Effects of ayahuasca on the development of ethanol-induced behavioral sensitization and on a post-sensitization treatment in mice Mice 2015 Experimental study

Citations in the library

Cited by 44

and 39 more in the library

Cites 25

and 20 more in the library

Related reading

Explore topics

Ayahuasca Serotonin Addiction Depression